mhurhangee/patent-ind-claim-en huggingface dataset:
A fixing device (501; 601) for attaching an item to a suspended plasterboard wall or ceiling, the fixing device comprising: a plug portion (504; 604) for securing in a hole in the suspended plasterboard wall or ceiling, the plug portion comprising an aperture (506; 606) for receiving a fastener that extends in a first direction; a longitudinal backplate (502; 602) that extends in a second direction and is attached to and projects from diametrically opposite sides of the plug portion, wherein the backplate is arranged in use to engage with the rear face of the suspended plasterboard wall or ceiling when the plug portion is secured in the hole; characterised in that : an outer wall of the plug portion comprises a screw thread ; the perimeter of the cross section of the plug portion in a plane perpendicular to the first direction has a minimum bounding circle having a first diameter; and the perimeter of the cross section of the fixing device through the plug portion in a plane perpendicular to the second direction has a minimum bounding circle having a second diameter less than or equal to the first diameter. a plug portion (504; 604) for securing in a hole in the suspended plasterboard wall or ceiling, the plug portion comprising an aperture (506; 606) for receiving a fastener that extends in a first direction; a longitudinal backplate (502; 602) that extends in a second direction and is attached to and projects from diametrically opposite sides of the plug portion, wherein the backplate is arranged in use to engage with the rear face of the suspended plasterboard wall or ceiling when the plug portion is secured in the hole; characterised in that : an outer wall of the plug portion comprises a screw thread ; the perimeter of the cross section of the plug portion in a plane perpendicular to the first direction has a minimum bounding circle having a first diameter; and the perimeter of the cross section of the fixing device through the plug portion in a plane perpendicular to the second direction has a minimum bounding circle having a second diameter less than or equal to the first diameter. an outer wall of the plug portion comprises a screw thread ; the perimeter of the cross section of the plug portion in a plane perpendicular to the first direction has a minimum bounding circle having a first diameter; and the perimeter of the cross section of the fixing device through the plug portion in a plane perpendicular to the second direction has a minimum bounding circle having a second diameter less than or equal to the first diameter.
A microfluidic device for determining the transepithelial electrical resistance (TEER) of a cell layer or a cell assembly and/or for determining the impedance of cells, a cell layer or a cell assembly, said device comprising at least one microchannel comprising at least a lower and an upper compartment characterised in that said upper and lower compartments are separated by at least two porous membranes and at least one inner compartment , the lower compartment comprising a bottom wall and side walls , the upper compartment comprising an upper wall and side walls , the bottom and upper wall , the side walls and the at least two porous membranes defining compartment volumes, wherein at least one porous membrane comprises on its surface at least one electrode , wherein the at least two porous membranes and side walls define the at least one inner compartment volume being positioned between the lower and the upper compartment.
A battery pack diagnosing device mediating signal communication between a battery pack and a user terminal, the battery pack diagnosing device comprising: a first connection terminal electrically connected to at least one of the battery pack and an apparatus equipped with the battery pack; a first switch for changing a communication mode with the apparatus connected to the first connection terminal based on a user input; a second switch for applying power to the battery pack diagnosing device based on a user input; a second connection terminal for supplying power to the battery pack diagnosing device; a communication unit for exchanging signals with the user terminal; a third switch for acquiring a user input for transmitting a wake-up signal to the battery pack; and a controller electrically connected to the first switch, the second switch, the third switch, the first connection terminal, the second connection terminal, and the communication unit, wherein the controller is configured to generate the wake-up signal based on a user input to the third switch and to transmit the generated wake-up signal to the battery pack through the first connection terminal, and to establish a communication connection according to a first communication method with the battery pack turned on based on the wake-up signal and to receive state information of the battery pack through the established communication connection. a first connection terminal electrically connected to at least one of the battery pack and an apparatus equipped with the battery pack; a first switch for changing a communication mode with the apparatus connected to the first connection terminal based on a user input; a second switch for applying power to the battery pack diagnosing device based on a user input; a second connection terminal for supplying power to the battery pack diagnosing device; a communication unit for exchanging signals with the user terminal; a third switch for acquiring a user input for transmitting a wake-up signal to the battery pack; and a controller electrically connected to the first switch, the second switch, the third switch, the first connection terminal, the second connection terminal, and the communication unit, wherein the controller is configured to generate the wake-up signal based on a user input to the third switch and to transmit the generated wake-up signal to the battery pack through the first connection terminal, and to establish a communication connection according to a first communication method with the battery pack turned on based on the wake-up signal and to receive state information of the battery pack through the established communication connection.
A therapeutic agent for use in treating an RNA viral infection, which comprises a combination of a pyrazine derivative represented by the following formula or a salt thereof and one or more types of compounds selected from the group consisting of an antifolate, a thiopurine antimetabolite, thiazofurin, an alkylating agent, and a xanthine derivative: wherein R 1 and R 2 , which are the same or different, each represent a hydrogen atom or a halogen atom; and R 3 represents a hydrogen atom or an amino-protecting group, and wherein the antifolate is methotrexate or pralatrexate, the thiopurine antimetabolite is a mercaptopurine derivative represented by the following formula : wherein R 4 represents a hydrogen atom or an optionally protected amino group; and R 5 represents a hydrogen atom or the following formula : (wherein R 6 represents a hydrogen atom, a C 1-6 alkyl group, or a carboxy group; and R 7 represents a hydrogen atom, a C 1-6 alkyl group, a benzyl group, or a p-nitrobenzyl group), the alkylating agent is temozolomide, and the xanthine derivative is theophylline. the antifolate is methotrexate or pralatrexate, the thiopurine antimetabolite is a mercaptopurine derivative represented by the following formula : wherein R 4 represents a hydrogen atom or an optionally protected amino group; and R 5 represents a hydrogen atom or the following formula : (wherein R 6 represents a hydrogen atom, a C 1-6 alkyl group, or a carboxy group; and R 7 represents a hydrogen atom, a C 1-6 alkyl group, a benzyl group, or a p-nitrobenzyl group), the alkylating agent is temozolomide, and the xanthine derivative is theophylline.
A method of producing a veneered element (10; 20), comprising providing a substrate and a wood veneer layer (5; 21) having a first surface (14; 35) and a second surface (15; 36), the first surface (14; 35) being opposite to the second surface (15; 36), arranging an adhesive layer on the substrate and/or on the first surface (14; 35) of the wood veneer layer (5; 21), arranging the wood veneer layer (5; 21) on the substrate , pressing the wood veneer layer (5; 21) to the substrate , wherein, after pressing, adhesive from the adhesive layer is present in a first portion (11; 31) of the wood veneer layer (5; 21) extending from the first surface (14; 35) of the wood veneer layer (5; 21) and into at least 10% of the thickness of the wood veneer layer (5; 21), wherein, after pressing, the second surface (15; 36) of the wood veneer layer (5; 21) is substantially free from adhesive from the adhesive layer , and wherein, after pressing, the wood veneer layer (5; 21) is compressed to a thickness being less than or equal to 80% of its thickness prior to pressing, wherein, after pressing, a second portion of the wood veneer layer (5; 21) extending from the second surface (15; 36) of the wood veneer layer (5; 21) and into the wood veneer layer (5; 21) is substantially free from adhesive from the adhesive layer , and wherein the second portion (12; 32) of the wood veneer layer (5; 21) is extending from the second surface (15; 36) of the wood veneer layer (5; 21) and into at least 70% of the thickness of the wood veneer layer (5; 21, wherein by substantially free from adhesive from the adhesive layer is meant that at least 70% of the surface of the second surface of the wood veneer layer is free from adhesive from the adhesive layer.
A kit for detecting gastrin-17, characterized in that it comprises a component A and a component B, wherein the component A is a first anti-gastrin-17 antibody labeled with a trace marker or coated on a magnetic sphere, the component B is a second anti-gastrin-17 antibody labeled with a trace marker or coated on a magnetic sphere; wherein either one of the components A and B is labeled with a trace marker and the other one is coated on a magnetic sphere; wherein the first anti-gastrin-17 antibody and the second anti-gastrin-17 antibody have different binding sites for binding with gastrin-17; and wherein the trace marker is at least one selected from the group consisting of luminol and derivatives thereof, isoluminol and derivatives thereof, acridinium esters; wherein the trace marker directly labels the first or second anti-gastrin-17 antibody, and wherein the first or second anti-gastrin-17 antibody is directly coated on the magnetic sphere.
A hemostatic device comprising: a covering member configured to be disposed on a finger of a patient to cover a site (t1) on a dorsal side (Hb) of a hand (H) of the patient where bleeding is to be stopped; a pressing member configured to compress the site (t1) where the bleeding is to be stopped in a state where the covering member covers the site (t1) where the bleeding is to be stopped; and a linear member configured to secure the covering member to the patient and constituted by a string-shaped member having a predetermined length and a predetermined outer diameter, wherein the covering member has a hole portion into which the linear member is inserted, wherein the linear member has a connection portion which is connected to the covering member , wherein the linear member is configured to form a space into which a portion of the linear member can be inserted between the covering member and the linear member to secure the covering member to the hand (H) of the patient in a state where the linear member is inserted into the hole portion , and wherein the pressing member is disposed on a distal side of the covering member relative to a virtual line (C1) passing through the hole portion and the connection portion . a covering member configured to be disposed on a finger of a patient to cover a site (t1) on a dorsal side (Hb) of a hand (H) of the patient where bleeding is to be stopped; a pressing member configured to compress the site (t1) where the bleeding is to be stopped in a state where the covering member covers the site (t1) where the bleeding is to be stopped; and a linear member configured to secure the covering member to the patient and constituted by a string-shaped member having a predetermined length and a predetermined outer diameter, wherein the covering member has a hole portion into which the linear member is inserted, wherein the linear member has a connection portion which is connected to the covering member , wherein the linear member is configured to form a space into which a portion of the linear member can be inserted between the covering member and the linear member to secure the covering member to the hand (H) of the patient in a state where the linear member is inserted into the hole portion , and wherein the pressing member is disposed on a distal side of the covering member relative to a virtual line (C1) passing through the hole portion and the connection portion .
Drive mechanism for a medicament delivery device, wherein the medicament delivery device comprises a housing for accommodating a medicament container and said drive mechanism and wherein the drive mechanism comprises: - a plunger rod arranged to act on a stopper arranged in the medicament container ; - a compression drive spring operably connected to said plunger rod and capable of applying a force on said plunger rod ; - a spring guide arranged coaxial with, and radially outside, said compression drive spring , capable of preventing buckling of said drive spring, characterized in that said spring guide comprises: - a tubular body extending along a length of said compression drive spring , and - a resilient force element comprising a spring guide spring which has a winding direction that is opposite the winding direction of said compression drive spring and which is arranged coaxial with, and radially outside said compression drive spring between a proximally directed surface of said tubular body and a distally directed surface of said medicament container for applying a force on said medicament container . - a plunger rod arranged to act on a stopper arranged in the medicament container ; - a compression drive spring operably connected to said plunger rod and capable of applying a force on said plunger rod ; - a spring guide arranged coaxial with, and radially outside, said compression drive spring , capable of preventing buckling of said drive spring, - a tubular body extending along a length of said compression drive spring , and - a resilient force element comprising a spring guide spring which has a winding direction that is opposite the winding direction of said compression drive spring and which is arranged coaxial with, and radially outside said compression drive spring between a proximally directed surface of said tubular body and a distally directed surface of said medicament container for applying a force on said medicament container .
A turbomachine passage cleaning system comprising: a first airflow passage having a first inlet configured and disposed to fluidly connect to a compressor portion , a first outlet configured and disposed to fluidly connected to a turbine portion , and a first intermediate portion that extends between the first inlet and the first outlet ; a first strainer arranged in the first intermediate portion; a second airflow passage fluidly coupled to the first airflow passage , the second airflow passage having a second inlet arranged upstream of the first inlet , a second outlet arranged downstream of the first outlet , and a second intermediate portion that extends between the second inlet and the second outlet ; a second strainer arranged in the second intermediate portion ; a first valve arranged in the first intermediate portion upstream from the first strainer and downstream from the first inlet ; and a second valve arranged in the second intermediate portion upstream from the second strainer and downstream from the second inlet , the first and second valves being selectively operated to control fluid flow into respective ones of the first and second airflow passages to filter air passing from a turbomachine compressor portion to a turbomachine turbine portion ; and a steam injection system fluidly coupled to one of the first and second airflow passages and configured to selectively deliver a cleansing flow of steam through the one of the first and second airflow passages towards the turbine portion . a first airflow passage having a first inlet configured and disposed to fluidly connect to a compressor portion , a first outlet configured and disposed to fluidly connected to a turbine portion , and a first intermediate portion that extends between the first inlet and the first outlet ; a first strainer arranged in the first intermediate portion; a second airflow passage fluidly coupled to the first airflow passage , the second airflow passage having a second inlet arranged upstream of the first inlet , a second outlet arranged downstream of the first outlet , and a second intermediate portion that extends between the second inlet and the second outlet ; a second strainer arranged in the second intermediate portion ; a first valve arranged in the first intermediate portion upstream from the first strainer and downstream from the first inlet ; and a second valve arranged in the second intermediate portion upstream from the second strainer and downstream from the second inlet , the first and second valves being selectively operated to control fluid flow into respective ones of the first and second airflow passages to filter air passing from a turbomachine compressor portion to a turbomachine turbine portion ; and a steam injection system fluidly coupled to one of the first and second airflow passages and configured to selectively deliver a cleansing flow of steam through the one of the first and second airflow passages towards the turbine portion .
A composition comprising a sensitizer for use in a method of treatment of cancer by hyperthermia therapy, the method comprising supplying the composition to an individual with cancer and applying a hyperthermia therapy at a temperature of between 39°C and 41°C to the individual with cancer, wherein the sensitizer enhances the effects of hyperthermia therapy, wherein the sensitizer comprises a combination of selenium and fish oil, wherein the composition comprises between 500 ng/ml and 1500 ng/ml of selenium and fish oil comprising between no mg and 330 mg of docosahexaenoic acid (DHA) and between 160 mg and 500 mg of eicosapentaenoic acid (EPA), and wherein the selenium and fish oil synergistically increase the sensitivity of cancer cells to hyperthermia at a temperature of between 39°C and 41°C, more than the selenium or the fish oil alone. wherein the sensitizer comprises a combination of selenium and fish oil, wherein the composition comprises between 500 ng/ml and 1500 ng/ml of selenium and fish oil comprising between no mg and 330 mg of docosahexaenoic acid (DHA) and between 160 mg and 500 mg of eicosapentaenoic acid (EPA), and wherein the selenium and fish oil synergistically increase the sensitivity of cancer cells to hyperthermia at a temperature of between 39°C and 41°C, more than the selenium or the fish oil alone.
A lung care system comprising: a portable multiple use module including a portable chassis; a first electromechanical connector disposed on the portable multiple use module; a single use disposable module including: a disposable structure including an interface circuit board and a second electromechanical connector disposed on the disposable structure, that is sized and shaped for interlocking the single use disposable module with the multiple use module for electromechanical inter-operation with the multiple use module, wherein the second electromechanical connector is configured to electromechanically couple to the first electromechanical connector to enable communication between the multiple use module and the interface circuit board, and a lung chamber assembly having a first interface for allowing a flow of perfusion fluid into the lung , a second interface for allowing ventilation of the lung, and a third interface for allowing a flow of the perfusion fluid away from the lung; a pump adapted to flow the perfusion fluid into and away from the lung; and a respiratory gas source having a predetermined composition of oxygen. a portable multiple use module including a portable chassis; a first electromechanical connector disposed on the portable multiple use module; a single use disposable module including: a disposable structure including an interface circuit board and a second electromechanical connector disposed on the disposable structure, that is sized and shaped for interlocking the single use disposable module with the multiple use module for electromechanical inter-operation with the multiple use module, wherein the second electromechanical connector is configured to electromechanically couple to the first electromechanical connector to enable communication between the multiple use module and the interface circuit board, and a lung chamber assembly having a first interface for allowing a flow of perfusion fluid into the lung , a second interface for allowing ventilation of the lung, and a third interface for allowing a flow of the perfusion fluid away from the lung; a disposable structure including an interface circuit board and a second electromechanical connector disposed on the disposable structure, that is sized and shaped for interlocking the single use disposable module with the multiple use module for electromechanical inter-operation with the multiple use module, wherein the second electromechanical connector is configured to electromechanically couple to the first electromechanical connector to enable communication between the multiple use module and the interface circuit board, and a lung chamber assembly having a first interface for allowing a flow of perfusion fluid into the lung , a second interface for allowing ventilation of the lung, and a third interface for allowing a flow of the perfusion fluid away from the lung; a pump adapted to flow the perfusion fluid into and away from the lung; and a respiratory gas source having a predetermined composition of oxygen.
An equipment for winding medical tubing, comprising: (i) one or more conveying units arranged for conveying medical tubing to one or more bending units ; (ii) one or more said bending units arranged for bending medical tubing in a U shape; (iii) one or more loading units adapted for individually picking and transporting each medical tubing after its bending; (iv) one or more winding units for winding medical tubing , comprising a winding nest arranged for receiving medical tubing from said loading unit , and a winding module adapted for winding medical tubing after its deposition into said winding nest . (i) one or more conveying units arranged for conveying medical tubing to one or more bending units ; (ii) one or more said bending units arranged for bending medical tubing in a U shape; (iii) one or more loading units adapted for individually picking and transporting each medical tubing after its bending; (iv) one or more winding units for winding medical tubing , comprising a winding nest arranged for receiving medical tubing from said loading unit , and a winding module adapted for winding medical tubing after its deposition into said winding nest .